Search results
Pfizer Inc. Just Beat EPS By 61%: Here's What Analysts Think Will Happen Next
Simply Wall St. via Yahoo Finance· 16 hours agoPfizer Inc. (NYSE:PFE) just released its first-quarter report and things are looking bullish. It was...
Pfizer Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 4 days agoPfizer Inc (NYSE:PFE) recently announced a dividend of $0.42 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-09. As investors...
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 4 days agoPfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn...
A Struggling Pfizer Looks for Help From a Wall Streeter
Barrons.com· 1 day agoAs the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a...
Pfizer agrees to settle 10K Zantac lawsuits, as GSK trial links heartburn drug to cancer
BenefitsPRO· 3 days agoPfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its...
Top Stock Reports for Amazon.com, Visa & Pfizer
Zacks via Yahoo Finance· 1 day agoToday's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE). These...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoStrengths highlight Pfizer's robust product portfolio and global market presence. Weaknesses underscore the challenges in revenue fluctuations and patent...
Pfizer reports patient death in Duchenne gene therapy study
Reuters via AOL· 4 days ago(Reuters) -A young patient died due to cardiac arrest after receiving Pfizer's experimental gene...
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 6 days agoSTOCK ALERT Andrew Baum, the prominent Wall Street drug company analyst, has never been much of a...
Is Pfizer Stock Fully Valued At $28?
Forbes· 5 days agoPfizer (NYSE: PFE) reported its Q1 results last week, with revenues and earnings beating the street estimates.